Drugs / 68Ga-DOTA/NOTA-FAPI-04
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04499365 | Aug 2020 → Dec 2023 | metastatic neoplasm, neoplasm | First Affiliated Hospital of Fujian Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-DOTA/NOTA-FAPI-04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04499365 ↗ |
| Modality | Diagnostic / imaging agent | “68Ga-DOTA/NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions” NCT04499365 ↗ |
| Route | Intravenous | “single intravenous injection of 68Ga-DOTA/NOTA-FAPI-04” NCT04499365 ↗ |